Tagged Articles

blood clots 301 articles

Heart device may eliminate need for heparin, warfarin

A small device implanted in the heart to stop blood clots from triggering strokes could serve as an alternative to blood thinners such as heparin and warfarin, according to a new study conducted by the device’s maker, Atritech, Inc. The device, called the Watchman, is designed specifically for patients with atrial fibrillation, a type of irregular heartbeat. Blood tends to pool in the atrial chamber of individuals with atrial fibrillation, which can lead to clotting and an increased risk for strokes. Patients with atrial fibrillation are generally treated with blood thinners to help prevent blood clots from forming. However, blood ... Read More

Canadian groups issue label change on birth control patch

Canadian pharmaceutical company Janssen-Ortho, Inc. in cooperation with Health Canada has issued a press release updating information on the average daily release rates of contraceptive hormones from the EVRA Transdermal Contraceptive System (patch) that is marketed in Canada and approved for use for the prevention of pregnancy. EVRA is bioequivalent to Ortho Evra, the birth control patch that is marketed in the United States. EVRA’s product information now includes average daily release rates for norelgestromin (200 micrograms every 24 hours) and ethinyl estradiol (35 micrograms every 24 hours). This information replaces the previously labeled daily delivery rate of norelgestromin (150 ... Read More

Researcher awarded NIH grant for development of synthetic heparin

A researcher at the University of North Carolina at Chapel Hill received a $1.48 million grant from the National Institutes of Health to support research into Recomparin, a synthetic version of the blood thinner heparin, according to the Triangle Business Journal. Associate Professor of Pharmacy Jian Liu invented the synthetic anticoagulant and hopes the grant money will help him perfect the drug and find better ways of synthesizing it. Heparin is routinely given to patients before certain types of surgery and prior to treatments such as kidney dialysis to prevent blood clots from forming. Clots that do not naturally dissolve ... Read More

Plan First! offers free health services, birth control

A new program in Wayne County, Michigan, is giving financially strapped women access to free family planning services, health care and birth control. However, women should be advised to consider their birth control options even if they come at no cost. The Plan First! program is an outreach by the Wayne County Department of Public Health and targets low-income women between the ages of 19 and 44 who are U.S. citizens or qualified legal residents, are not currently pregnant and are not covered by Medicaid or other family planning coverage. The Plan First! program offers a wide variety of women’s ... Read More

J&J settles lawsuits with Canadian women harmed by birth control patch

Johnson & Johnson, the makers of the Ortho Evra contraceptive patch for women, has agreed to settle lawsuits filed by Canadian women who suffered from blood clots, heart attacks or strokes after using the patch. The drug maker avoided trial by spending more than $68 million to settle similar claims by women in the United States, according to Bloomberg. The Ortho Evra patch was originally marketing to young women who were turned off by the notion of taking a once-daily pill for contraception. The patch is replaced after a week. However, the patch was found in some cases to seep ... Read More

Women should spend more time weighing risks of birth control options

A British survey suggests one in three women spend no more than five minutes selecting a suitable contraceptive method to use, according to Medical News Today. The report, conducted by Family Planning Association, is part of the organization’s Finding the Perfect Partner (Choose What You Use) campaign to help reduce unplanned pregnancy and abortion, and to promote greater control over contraceptive choice among women and health professionals. It found that despite the seemingly little care women put into the decision of what type of birth control to use, nearly half have had an unwanted pregnancy scare. “Another issue is that ... Read More

TCU students urged to heed contraception patch warnings

Students at Texas Christian University (TCU) now have access to more affordable contraceptives through the university’s Health Center, according to the TCU news Web site Daily Skiff. The Health Center negotiated a contract with drug companies to offer the discounted rates to students requesting contraceptives such as Ortho Tri-Cyclen and the Ortho Evra Contraceptive Transdermal Patch. However, students may want to weigh their contraception options more closely. Johnson & Johnson, the makers of the Ortho Evra contraceptive patch has been riddled with lawsuits claiming the patches cause serious side effects in young women, such as blood clots and even death. ... Read More

Another J&J patch causing deaths in users

Drug maker Johnson & Johnson is recalling another one of its patches, the Duragesic fentanyl pain patch. According to BNet Business Network, the fentanyl patch is highly addictive and has been linked to deaths caused by the patches to leak too much medicine into the body. This is the fifth recall of Duragesic fentanyl patch since 1994. Patches have caused much pain for Johnson & Johnson. Last year, the company paid $68 million to settle lawsuits against the company’s birth control patch, Ortho Evra. The patch was linked to at least 40 deaths caused by blood clots. Ortho Evra was originally ... Read More

Czech 'heparin murderer' gets life in prison

Petr Zelenka liked the excitement around crisis situations and the constant activity of hospital staff, which is why he pursued a position at an anaesthesiological-resuscitation ward at Havlickuv Brod hospital in the Czech Republic. To further his excitement, he administered heparin to patients between May and September 2006, which resulted in serious health complications and even death in some patients. Heparin is a blood thinner used to prevent blood clots. It is often given before surgery and during treatments such as kidney dialysis to prevent clotting. In appropriate use or overdosing can be fatal. This week, Zelenka – known to ... Read More

Celgene issues letter warning of limited use of heparin drug

Just weeks after the FDA requested revised labeling for the low molecular weight heparin, Innohep, the FDA announced that its maker Celgene Corporation has issued a “Dear Healthcare Professional” letter describing a controlled clinical study that suggests an increased risk of death in elderly patients who received Innohep. Innohep contains tinzaparin sodium that is given to patients in conjunction with warfarin sodium intravenously to treat blood clots that have occurred deep in the veins of hospitalized patients who may or may not have also experienced the occurrence of blood clots in their lungs (pulmonary embolism). In early December, the FDA ... Read More